ImmunityBio
IBRX
#2331
Rank
S$10.61 B
Marketcap
S$10.02
Share price
-1.01%
Change (1 day)
226.48%
Change (1 year)

Market capitalization of ImmunityBio (IBRX)

Market cap: S$10.61 Billion

As of September 2026 ImmunityBio has a market cap of S$10.61 Billion. This makes ImmunityBio the world's 2331th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ImmunityBio from 2021 to 2026

End of year Market Cap

Year Marketcap Change
2026S$10.61 B292.25%
2025S$2.70 B-1.92%
2024S$2.75 B-37.67%
2023S$4.42 B62.7%
2022S$2.72 B-16.79%
2021S$3.26 B

End of Day market cap according to different sources

On Sep 1st, 2026 the market cap of ImmunityBio was reported to be:

S$10.61 Billion
by Nasdaq info icon info icon
S$10.61 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
S$1.70 B-83.98%๐Ÿ‡บ๐Ÿ‡ธ USA